Batch BeaconUK recalls and safety alerts

Medicines recallMHRA

Ramipril 10mg capsules recalled over a quality concern

Medicine quality concernHigh riskClass 2

Crescent Pharma Limited is recalling one batch of Ramipril 10mg Capsules as a precautionary measure due to a potential error at the manufacturing site.

Check your product

Only products that match these details are covered. Have your pack in front of you.

3 identifiers listed for this notice.

  • Ramipril 10mg capsules 28

    Batch codePrinted on the pack, often next to the date mark. It may start with L or LOT.
    • GR174091
    ExpiryOn the carton, blister or label.
    • 10/2026
    First distributedOn the product, its label or its packaging.
    • 13 May 2025

What to do now

Affected batches of Ramipril 10mg capsules are subject to a recall or defect notice.

  1. Do not stop taking a prescribed medicine without advice: missing doses can be more dangerous than the defect.
  2. Compare the batch number printed on the box or label with the batches listed here.
  3. If your pack is affected, take it to your pharmacy or contact the prescriber for a replacement.
  4. Any side effect you think is linked can be reported through the Yellow Card scheme.

Why it matters. The MHRA classifies medicines recalls from Class 1 (most serious) to Class 4 (caution in use). The notice below sets out the details.

Symptoms and when to get help

Look out for

  • a side effect you have not had before
  • your condition not being controlled as well as usual

Get help urgently

  • signs of a severe allergic reaction, such as swelling of the face or throat or difficulty breathing — call 999
  • if you feel unwell and are worried, speak to a pharmacist, your GP or NHS 111

This is general information based on NHS public guidance, not medical advice. In an emergency call 999. For urgent advice use NHS 111 (NHS 24 on 111 in Scotland) or, in Northern Ireland, your GP or out-of-hours service.

Replacements and prescriptions

Talk to the pharmacist who dispensed the medicine. They have the batch information and can arrange a replacement.

If you bought it over the counter, return it to the pharmacy or shop for a refund or replacement.

From the official notice

Published by the Medicines and Healthcare products Regulatory Agency (EL(26)A/19). Quoted as issued.

Summary

Crescent Pharma Limited is recalling one batch of Ramipril 10mg Capsules as a precautionary measure due to a potential error at the manufacturing site.

The risk

DMRC reference number DMRC- 39191133 Marketing Authorisation Holder

Advice for healthcare professionals

Stop supplying the impacted batch of Ramipril 10mg Capsules (Batch No GR174091) immediately. Quarantine all remaining stock and return it to your supplier using your approved process.

If batch/product traceability information is available, pharmacy professionals and other healthcare professionals involved in dispensing medicinal products should identify and immediately contact all patients who have been dispensed the impacted product and ask them to confirm if they have remaining stock within their possession for return.

If batch/product traceability information is not available, pharmacists should identify all patients dispensed this product between 13 May 2025 and 16 April 2026. Where appropriate and feasible, contact all patients who have dispensed the impacted product with priority given to those who have been dispensed the product most recently and within the last 28 days. The majority of this was distributed in 2025 and therefore it is expected that many of these packs will have been dispensed to patients and consumed.

Some cartons of Ramipril 10mg Capsules, manufactured by Crescent Pharma Limited, may contain blister strips of Ramipril 5 mg Capsule.

All packs from the impacted batch of Ramipril 10 mg Capsule, (Batch Number GR174091) are being recalled as a precautionary measure.

If you were prescribed Ramipril 10 mg Capsules and have received the impacted product batch (Batch Number GR174091) please check that the carton contains the correct medication. The batch number and expiry date information can be found on outer carton.

If the carton contains blister strips that are labelled and contain Ramipril 5 mg capsule, contact your dispensing pharmacy in the first instance. If the carton contains blister strips that are labelled and contain Ramipril 10 mg Capsules, you do not need to take further action.

If you are unsure or have any questions, please seek advice from your pharmacy or other healthcare professionals responsible for your care.

Please take the leaflet that came with your medicine and any remaining capsules with you to your pharmacy or GP practice.

Both strengths are used to treat high blood pressure, heart failure and kidney disease. Any possible impact of a lower dose of ramipril is expected to be gradual rather than immediate or life threatening.

For reference, the description of the products are as follows:

Ramipril 10 mg Capsules: Capsules are light grey and dark green capsules, marked with “R” on the cap and “10” on the body.

Advice for patients

Some cartons of Ramipril 10mg Capsules, manufactured by Crescent Pharma Limited, may contain blister strips of Ramipril 5 mg Capsule.

All packs from the impacted batch of Ramipril 10 mg Capsule, (Batch Number GR174091) are being recalled as a precautionary measure.

If you were prescribed Ramipril 10 mg Capsules and have received the impacted product batch (Batch Number GR174091) please check that the carton contains the correct medication. The batch number and expiry date information can be found on outer carton.

If the carton contains blister strips that are labelled and contain Ramipril 5 mg capsule, contact your dispensing pharmacy in the first instance. If the carton contains blister strips that are labelled and contain Ramipril 10 mg Capsules, you do not need to take further action.

If you are unsure or have any questions, please seek advice from your pharmacy or other healthcare professionals responsible for your care.

Please take the leaflet that came with your medicine and any remaining capsules with you to your pharmacy or GP practice.

Both strengths are used to treat high blood pressure, heart failure and kidney disease. Any possible impact of a lower dose of ramipril is expected to be gradual rather than immediate or life threatening.

For reference, the description of the products are as follows:

Ramipril 10 mg Capsules: Capsules are light grey and dark green capsules, marked with “R” on the cap and “10” on the body.

Ramipril 5mg Capsule: Capsules are light grey and green gelatin capsules, marked with “R” on the cap and “5” on the body.

See below for images showing the different medicines and where to find the batch number of the product and the identification of the incorrect blister strip.

Ramipril 10 mg Capsules – Batch GR174091 Outer carton and BN/Exp Date information

Open the MHRA notice

Questions

Why has Ramipril 10mg capsules been recalled?

Affected batches of Ramipril 10mg capsules are subject to a recall or defect notice. The MHRA classifies medicines recalls from Class 1 (most serious) to Class 4 (caution in use). The notice below sets out the details.

How do I know if my medicine is affected?

Compare the batch code, expiry and date code on your pack with the details listed under “Check your product” on this page. Only items that match are covered by the notice.

What should I do now?

Do not stop taking a prescribed medicine without advice: missing doses can be more dangerous than the defect. Compare the batch number printed on the box or label with the batches listed here.

Do I need a new prescription?

Talk to the pharmacist who dispensed the medicine. They have the batch information and can arrange a replacement. If you bought it over the counter, return it to the pharmacy or shop for a refund or replacement.

Related notices